The Center for Cell Reprogramming pursues and promotes research on stem-like cells, with an emphasis on conditionally reprogrammed cells, adult stem cells and their relevant biological/medical applications. We serve as a nidus for faculty recruitment, for internal and external research collaborations, and for facilitating funding from the National Institutes of Health, Department of Defense, pharmaceutical companies and foundations. We currently sponsor seminars by world-class scientists to maintain the Center at the forefront of the rapidly advancing field of cell reprogramming. Our basic goal is to perform groundbreaking investigations in predictive and regenerative medicine. For example, we have research groups focusing on the genetic heterogeneity of cancers, the biomarkers of indolent versus aggressive cancers, and the analysis of patient-specific responses (and resistance) to drug and immunologic therapies. In addition, we have other research groups applying these technologies to liver and pancreatic islet cell transplantation. Ultimately, we hope to integrate stem cell biology into the existing basic, translational and clinical programs at Georgetown University Medical Center.